Oncology Nursing Society (ONS)

The Oncology Nursing Society (ONS) is a professional association that represents 100,000 nurses and is the professional home to more than 35,000 members. ONS is committed to promoting excellence in oncology nursing and the transformation of cancer care. Since 1975, ONS has provided a professional community for oncology nurses, developed evidence-based education programs and treatment information, and advocated for patient care, all in an effort to improve the quality of life and outcomes for patients with cancer and their families.
Trastuzumab is a monoclonal antibody used for the treatment of HER2-positive breast cancer. Despite the efficacy of trastuzumab in the adjuvant setting, 1 in 4 patients experience disease recurrence. Neratinib is a potent, irreversible, pan-HER tyrosine kinase inhibitor that can combat mechanisms of disease escape and recurrence experienced with other HER2-targeted therapies. Read More ›

The 2015 Annual Congress of the Oncology Nursing Society (ONS) marks the 40th anniversary of the organization. Presentations and events included the tried and true and the new. Read More ›

The United States lags behind other developed countries in uptake of the human papillomavirus (HPV) vaccine, and nurses and other healthcare providers can improve the situation. Read More ›


Page 3 of 3